Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Metal Stent Patency in Malignant Distal Bile Duct Obstruction
NCT03279809Terminated
- Start
- Oct 2017
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in bile duct obstruction comparing Aspirin Group with Placebo Group (2 arms). Primary endpoint: Incidence of stent dysfunction at 6 months. Started Oct 2017; status: terminated.
02
Drugs
aspirin
03
Conditions
bile duct obstruction
Beyond the preview
Go deeper on NCT03279809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03279809.